Bile duct disorders can lead to serious complications if left untreated, but early diagnosis and proper management can ...

In a clinical report issued by the American Academy of Pediatrics and published online Feb. 18 in Pediatrics, recommendations ...

The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for the treatment of primary biliary cholangitis, the company announced in ...

Overlap syndromes show characteristics of both autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), or autoimmune cholangitis (AIC). (From Beuers U.

The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...